Physician profile
Grace Tseng
NPI 1780208330
$8,839.72
in general payments reported to CMS, 2019-2025
16 companies · $953 in 2025
The $953 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.67 · 2021: $5,809 · 2022: $676 · 2023: $284 · 2024: $1,068 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,547.13 | 2020-2025 | Misight Contact Lens, Paragon Crt |
| Valley Contax, INC. | $1,264.04 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $692.84 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $524.46 | 2021-2025 | |
| Visioneering Technologies, INC. | $333.28 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $304.81 | 2021-2024 | Xelpros, Cequa |
| Bausch & Lomb Americas INC. | $296.30 | 2022-2025 | Miebo, Alden Corneal Gp, Infuse |
| Alcon Vision LLC | $250.72 | 2024-2025 | Hydrus Microstent, Eysuvis, Tryptyr |
| Biotissue Holdings INC. | $220.90 | 2024-2025 | |
| Oyster Point Pharma, INC. | $123.35 | 2023 | Tyrvaya |
| Dompe US, INC. | $85.96 | 2023-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $53.48 | 2021-2022 | |
| Horizon Therapeutics Plc | $53.39 | 2023 | Tepezza |
| Allergan, INC. | $42.96 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.